Stay updated with breaking news from Nasdaq Rdus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Radius Health, Inc. (NASDAQ:RDUS – Get Rating) major shareholder Target N. V. Biotech acquired 477,824 shares of the company’s stock in a transaction on Wednesday, May 18th. The shares were bought at an average price of $5.57 per share, with a total value of $2,661,479.68. Following the completion of the purchase, the insider now directly […]
Radius Health, Inc. (NASDAQ:RDUS – Get Rating) has received an average recommendation of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and two have assigned a buy recommendation to the company. The […]
StockNews.com began coverage on shares of Radius Health (NASDAQ:RDUS – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Several other research analysts also recently weighed in on RDUS. Bank of America initiated coverage on Radius Health in a report on Friday, […]
UBS Asset Management Americas Inc. grew its stake in shares of Radius Health, Inc. (NASDAQ:RDUS – Get Rating) by 17.6% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 63,793 shares of the biopharmaceutical company’s stock after buying an additional 9,563 shares during the quarter. UBS Asset Management Americas Inc.’s holdings in Radius […]
Wellington Management Group LLP cut its stake in shares of Radius Health, Inc. (NASDAQ:RDUS – Get Rating) by 33.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,211,220 shares of the biopharmaceutical company’s stock after selling 1,115,818 shares during the quarter. Wellington Management […]